Indole IKZF2 Degraders for Stronger Antitumor Immune Response
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing compounds for degrading IKZF2 do not exhibit sufficient biological activity against cancer cells, limiting their effectiveness in promoting antitumor immune responses.
Innovation Solution
Development of indole derivative compounds represented by Chemical Formula 1, which include specific substitutions and functional groups, such as -C(O) (C6-C10) heteroaryl, to enhance the degradation of IKZF2 and induce antitumor immune responses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing compounds for degrading IKZF2 are used, then IKZF2 degradation is achieved, but biological activity against cancer cells is insufficient
Solution Approach 1:
The patent modifies the chemical structure parameters of existing IKZF2-degrading compounds by introducing specific substituents (R1-R7) and functional groups (-C(O)indole-, -C(O)(C6-C10)heteroaryl) to enhance biological activity. This involves changing molecular weight, hydrophobicity, and electronic properties to improve cancer cell targeting while maintaining IKZF2 degradation capability
Solution Approach 2:
The patent creates composite molecular structures by combining the core IKZF2-degrading scaffold with additional functional moieties (indole derivatives, heteroaryl groups). These composite structures integrate multiple pharmacophores that work synergistically to enhance antitumor activity while preserving the protein degradation function
2Productivity
If IKZF2 degradation is enhanced to promote antitumor immune responses, then Treg cell conversion to Teff cells increases, but off-target effects may increase
Solution Approach 1:
The patent introduces specific local substitutions (R2 as -C(O)(C6-C10)heteroaryl, R3-R7 various groups) at particular positions of the molecular scaffold to enhance binding affinity and selectivity for the target protein. This localized modification approach improves on-target activity while minimizing off-target interactions by maintaining specificity at critical binding interfaces
Solution Approach 2:
The patent employs specific molecular intermediaries (indole derivatives, heteroaryl groups) that facilitate selective interaction with the target protein. These intermediary structures act as molecular mediators that enhance the degradation process while providing steric and electronic shielding to prevent unwanted interactions with off-target proteins
Data Source
Figure (1-A)~(1-B)
AI summary
The present invention relates to an indole compound derivative that decomposes IKZF2 and a use thereof. More specifically, a compound of chemical formula 1 provides an agent having a novel mechanism of action against the IKZF2 protein, and thus is useful for the treatment of diseases and disorders related to the IKZF2 protein, and can in particular be effectively used for preventing or treating cancer.